Top Industry Leaders in the Anticoagulation Market
Latest Anticoagulation Companies Update:
Johnson & Johnson Completes Abiomed Acquisition Finalized in December 2022, this acquisition strengthens J&J's cardiovascular portfolio and adds Abiomed's innovative heart, lung, and kidney support technologies, potentially impacting anticoagulant use in these areas.
Bayer Partners with Rocket Pharma for New Oral Anticoagulant: In October 2023, Bayer collaborated with Rocket Pharma to develop Rivocetan, a potential next-generation oral Factor Xia inhibitor offering advantages over current options.
Boehringer Ingelheim Expands Pradaxa Reach: In June 2023, the FDA approved Pradaxa (dabigatran etexilate) for venous thromboembolism treatment in children between 3 months and 12 years, broadening their customer base.
Techdow USA Launches Heparin Sodium Injection: In February 2023, this vertically integrated generics company debuted its Heparin Sodium Injection, expanding access to this crucial anticoagulant in the US market.
List of Anticoagulation Key companies in the market
- Pfizer Inc (US)
- Novartis AG (Switzerland)
- Sanofi(France)
- GlaxoSmithKline plc (UK)
- Daiichi Sankyo Company, Limited (Japan)
- Johnson & Johnson Services Inc (US)
- Boehringer Ingelheim International GmbH (Germany)
- Bristol-Myers Squibb Company (US)
- Hoffmann-La Roche Ltd (Switzerland)
- Portola Pharmaceuticals, Inc (US)